1-U

CURRENT REPORT PURSUANT TO REGULATION A

Company: 20/20 Biolabs, Inc.
Filed: December 27, 2018
Period of Report: December 27, 2018
Accession Number: 0001213900-18-017915

View Document ↗ View on SEC.gov ↗